Publications

1. Abu Awwad D, Shafiq J, Delaney GP, Anacak Y, Bray F, Flores JA, et al. (2024). Current and projected gaps in the availability of radiotherapy in the Asia-Pacific region: a country income-group analysis. Lancet Oncol. 25(2):225–34. https://doi.org/10.1016/S1470-2045(23)00619-8 PMID:38301690
2. Benitez Fuentes JD, Morgan E, de Luna Aguilar A, Mafra A, Shah R, Giusti F, et al. (2024). Global Stage Distribution of Breast Cancer at Diagnosis: A Systematic Review and Meta-Analysis. JAMA Oncol. 10(1):71–8. https://doi.org/10.1001/jamaoncol.2023.4837 PMID:37943547
3. Bray F (2024). Cancer trends in the UK. BMJ. 384:q504. https://doi.org/10.1136/bmj.q504 PMID:38479756
4. Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. (2024). Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 74(3):229–63. https://doi.org/10.3322/caac.21834 PMID:38572751
5. Businge L, Hagenimana M, Motlhale M, Bardot A, Liu B, Anastos K, et al. (2024). Stage at diagnosis and survival by stage for the leading childhood cancers in Rwanda. Pediatr Blood Cancer. 71(7):e31020. https://doi.org/10.1002/pbc.31020 PMID:38668553
6. Corredor C, Piñeros M, Wiesner C, de Vries E (2024). Using administrative registries as a source for population-based cancer incidence and mortality. BMC Cancer. 24(1):232. https://doi.org/10.1186/s12885-023-11754-w PMID:38373947
7. de Paula Silva N, Colombet M, Moreno F, Erdmann F, Dolya A, Piñeros M, et al.; IICC-3 contributors (2024). Incidence of childhood cancer in Latin America and the Caribbean: coverage, patterns, and time trends. Rev Panam Salud Publica. 48:e11. https://doi.org/10.26633/RPSP.2024.11 PMID:38410357
8. Ghasemi-Kebria F, Fazel A, Semnani S, Etemadi A, Naeimi-Tabiei M, Hasanpour-Heidari S, et al. (2024). Breast cancer incidence trends in Golestan, Iran: An age-period-cohort analysis by ethnic region, 2004-2018. Cancer Epidemiol. 89:102525. https://doi.org/10.1016/j.canep.2024.102525 PMID:38228040
9. Guimarães Ribeiro A, Ferlay J, Vaccarella S, Dias de Oliveira Latorre MDR, Tavares Guerreiro Fregnani JH, Bray F (2024). Ethnic disparities in cancer mortality in the capital and northeast of the State of São Paulo, Brazil 2001-17. Cancer Causes Control. 35(3):523–9. https://doi.org/10.1007/s10552-023-01812-w PMID:37917366
10. James ND, Tannock I, N’Dow J, Feng F, Gillessen S, Ali SA, et al. (2024). The Lancet Commission on prostate cancer: planning for the surge in cases. Lancet. 403(10437):1683–722. https://doi.org/10.1016/S0140-6736(24)00651-2 PMID:38583453
11. Joko-Fru WY, Bardot A, Bukirwa P, Amidou S, N’da G, Woldetsadik E, et al. (2024). Cancer survival in sub-Saharan Africa (SURVCAN-3): a population-based study. Lancet Glob Health. 12(6):e947–59. https://doi.org/10.1016/S2214-109X(24)00130-X PMID:38762297
12. Koyanagi YN, Nakatochi M, Namba S, Oze I, Charvat H, Narita A, et al.; BioBank Japan Project (2024). Genetic architecture of alcohol consumption identified by a genotype-stratified GWAS and impact on esophageal cancer risk in Japanese people. Sci Adv. 10(4):eade2780. https://doi.org/10.1126/sciadv.ade2780 PMID:38277453
13. Kusters JMA, Diergaarde B, Ness A, Schim van der Loeff MF, Heijne JCM, Schroeder L, et al. (2024). Diagnostic accuracy of HPV16 early antigen serology for HPV-driven oropharyngeal cancer is independent of age and sex. Int J Cancer. 154(2):389–402. https://doi.org/10.1002/ijc.34710 PMID:37694289
14. Steinberg J, Hughes S, Hui H, Allsop MJ, Egger S, David M, et al. (2024). Risk of COVID-19 death for people with a pre-existing cancer diagnosis prior to COVID-19-vaccination: A systematic review and meta-analysis. Int J Cancer. 154(8):1394–412. https://doi.org/10.1002/ijc.34798 PMID:38083979
15. Wang S, Zheng R, Li J, Zeng H, Li L, Chen R, et al. (2024). Global, regional, and national lifetime risks of developing and dying from gastrointestinal cancers in 185 countries: a population-based systematic analysis of GLOBOCAN. Lancet Gastroenterol Hepatol. 9(3):229–37. https://doi.org/10.1016/S2468-1253(23)00366-7 PMID:38185129
16. Wéber A, Vignat J, Shah R, Morgan E, Laversanne M, Nagy P, et al. (2024). Global burden of bladder cancer mortality in 2020 and 2040 according to GLOBOCAN estimates. World J Urol. 42(1):237. https://doi.org/10.1007/s00345-024-04949-8 PMID:38625417
17. Zahed H, Feng X, Sheikh M, Bray F, Ferlay J, Ginsburg O, et al. (2024). Age at diagnosis for lung, colon, breast and prostate cancers: An international comparative study. Int J Cancer. 154(1):28–40. https://doi.org/10.1002/ijc.34671 PMID:37615573
18. Znaor A, Eser S, Bendahhou K, Shelpai W, Al Lawati N, ELBasmi A, et al. (2024). Stage at diagnosis of colorectal cancer in the Middle East and Northern Africa: A population-based cancer registry study. Int J Cancer. 155(1):54–60. https://doi.org/10.1002/ijc.34895 PMID:38456478
19. Ali MEAY, Nusselder W, Weiderpass E, Corbex M, Bray F, Vaccarella S (2023). Inequities in cancer outcomes. Bull World Health Organ. 101(9):550. https://doi.org/10.2471/BLT.23.290661 PMID:37663873
20. Banham D, Roder D, Thompson S, Williamson A, Bray F, Currow D (2023). The effect of general practice contact on cancer stage at diagnosis in Aboriginal and non-Aboriginal residents of New South Wales. Cancer Causes Control. 34(10):909–26. https://doi.org/10.1007/s10552-023-01727-6 PMID:37329444
21. Barchuk A, Tursun-Zade R, Nazarova E, Komarov Y, Tyurina E, Tumanova Y, et al. (2023). Completeness of regional cancer registry data in Northwest Russia 2008-2017. BMC Cancer. 23(1):994. https://doi.org/10.1186/s12885-023-11492-z PMID:37853404
22. Bauer M, Vetter M, Stückrath K, Yohannes M, Desalegn Z, Yalew T, et al. (2023). Regional Variation in the Tumor Microenvironment, Immune Escape and Prognostic Factors in Breast Cancer in Sub-Saharan Africa. Cancer Immunol Res. 11(6):720–31. https://doi.org/10.1158/2326-6066.CIR-22-0795 PMID:37058582
23. Bergengren O, Pekala KR, Matsoukas K, Fainberg J, Mungovan SF, Bratt O, et al. (2023). 2022 Update on Prostate Cancer Epidemiology and Risk Factors-A Systematic Review. Eur Urol. 84(2):191–206. https://doi.org/10.1016/j.eururo.2023.04.021 PMID:37202314
24. Blanco-Lopez J, Iguacel I, Pisanu S, Almeida CCB, Steliarova-Foucher E, Sierens C, et al. (2023). Role of Maternal Diet in the Risk of Childhood Acute Leukemia: A Systematic Review and Meta-Analysis. Int J Environ Res Public Health. 20(7):5428. https://doi.org/10.3390/ijerph20075428 PMID:37048042
25. Budhathoki S, Diergaarde B, Liu G, Olshan A, Ness A, Waterboer T, et al. (2023). A risk prediction model for head and neck cancers incorporating lifestyle factors, HPV serology and genetic markers. Int J Cancer. 152(10):2069–80. https://doi.org/10.1002/ijc.34444 PMID:36694401
26. Cabasag CJ, Arnold M, Rutherford M, Ferlay J, Bardot A, Morgan E, et al. (2023). Shifting incidence and survival of epithelial ovarian cancer (1995-2014): A SurvMark-2 study. Int J Cancer. 152(9):1763–77. https://doi.org/10.1002/ijc.34403 PMID:36533660
27. De Camargo Cancela M, Bezerra de Souza DL, Leite Martins LF, Borges L, Schilithz AO, Hanly P, et al. (2023). Can the sustainable development goals for cancer be met in Brazil? A population-based study. Front Oncol. 12:1060608. https://doi.org/10.3389/fonc.2022.1060608 PMID:36703792
28. De Camargo Cancela M, Monteiro Dos Santos JE, Lopes de Souza LB, Martins LFL, Bezerra de Souza DL, Barchuk A, et al. (2023). The economic impact of cancer mortality among working-age individuals in Brazil from 2001 to 2030. Cancer Epidemiol. 86:102438. https://doi.org/10.1016/j.canep.2023.102438 PMID:37579673
29. Deshmukh AA, Damgacioglu H, Georges D, Sonawane K, Ferlay J, Bray F, et al. (2023). Global burden of HPV-attributable squamous cell carcinoma of the anus in 2020, according to sex and HIV status: A worldwide analysis. Int J Cancer. 152(3):417–28. https://doi.org/10.1002/ijc.34269 PMID:36054026
30. Frick C, Rumgay H, Vignat J, Ginsburg O, Nolte E, Bray F, et al. (2023). Quantitative estimates of preventable and treatable deaths from 36 cancers worldwide: a population-based study. Lancet Glob Health. 11(11):e1700–12. https://doi.org/10.1016/S2214-109X(23)00406-0 PMID:37774721
31. Ghasemi-Kebria F, Jafari-Delouie N, Semnani S, Fazel A, Etemadi A, Norouzi A, et al. (2023). Colorectal cancer incidence trends in Golestan, Iran: An age-period-cohort analysis 2004-2018. Cancer Epidemiol. 86:102415. https://doi.org/10.1016/j.canep.2023.102415 PMID:37442047
32. Ghasemi-Kebria F, Semnani S, Fazel A, Etemadi A, Amiriani T, Naeimi-Tabiei M, et al. (2023). Esophageal and gastric cancer incidence trends in Golestan, Iran: An age-period-cohort analysis 2004 to 2018. Int J Cancer. 153(1):73–82. https://doi.org/10.1002/ijc.34518 PMID:36943026
33. Gini A, Colombet M, de Paula Silva N, Visser O, Youlden D, Soerjomataram I, et al.; CRICCS Consortium (2023). A new method of estimating prevalence of childhood cancer survivors (POCCS): example of the 20-year prevalence in The Netherlands. Int J Epidemiol. 52(6):1898–906. https://doi.org/10.1093/ije/dyad124 PMID:37738448
34. Ginsburg O, Vanderpuye V, Beddoe AM, Bhoo-Pathy N, Bray F, Caduff C, et al. (2023). Women, power, and cancer: a Lancet Commission. Lancet. 402(10417):2113–66. https://doi.org/10.1016/S0140-6736(23)01701-4 PMID:37774725
35. Guimarães Ribeiro A, Ferlay J, Piñeros M, Dias de Oliveira Latorre MDR, Tavares Guerreiro Fregnani JH, Bray F (2023). Geographic variations in cancer incidence and mortality in the State of São Paulo, Brazil 2001-17. Cancer Epidemiol. 85:102403. https://doi.org/10.1016/j.canep.2023.102403 PMID:37390700
36. Hanly P, Ortega Ortega M, Pearce A, de Camargo Cancela M, Soerjomataram I, Sharp L (2023). Estimating Global Friction Periods for Economic Evaluation: A Case Study of Selected OECD Member Countries. Pharmacoeconomics. 41(9):1093–101. https://doi.org/10.1007/s40273-023-01261-y PMID:37036642
37. Jubber I, Ong S, Bukavina L, Black PC, Compérat E, Kamat AM, et al. (2023). Epidemiology of Bladder Cancer in 2023: A Systematic Review of Risk Factors. Eur Urol. 84(2):176–90. https://doi.org/10.1016/j.eururo.2023.03.029 PMID:37198015
38. Kidayi PL, Pakpour AH, Saboonchi F, Bray F, Manhica H, Mtuya CC, et al. (2023). Cross-Cultural Adaptation and Psychometric Properties of the Swahili Version of the European Organization for Research and Treatment of Cancer (EORTC) QLQ-BR45 among Breast Cancer Patients in Tanzania. Healthcare (Basel). 11(18):15. https://doi.org/10.3390/healthcare11182467 PMID:37761665
39. Kiss Z, Kocsis J, Nikolényi A, Horváth Z, Knollmajer K, Benedek A, et al. (2023). Opposite trends in incidence of breast cancer in young and old female cohorts in Hungary and the impact of the Covid-19 pandemic: a nationwide study between 2011-2020. Front Oncol. 13:1182170. https://doi.org/10.3389/fonc.2023.1182170 PMID:37795445
40. Larønningen S, Skog A, Engholm G, Ferlay J, Johannesen TB, Kristiansen MF, et al. (2023). Nordcan.R: a new tool for federated analysis and quality assurance of cancer registry data. Front Oncol. 13:1098342. https://doi.org/10.3389/fonc.2023.1098342 PMID:37614501
41. Li M, Meheus F, Polazzi S, Delafosse P, Borson-Chazot F, Seigneurin A, et al.; Thyroid Cancer Group FRANCIM (2023). The Economic Cost of Thyroid Cancer in France and the Corresponding Share Associated With Treatment of Overdiagnosed Cases. Value Health. 26(8):1175–82. https://doi.org/10.1016/j.jval.2023.02.016 PMID:36921898
42. Li M, Park JY, Sheikh M, Kayamba V, Rumgay H, Jenab M, et al. (2023). Population-based investigation of common and deviating patterns of gastric cancer and oesophageal cancer incidence across populations and time. Gut. 72(5):846–54. https://doi.org/10.1136/gutjnl-2022-328233 PMID:36241389
43. Luo G, Zhang Y, Etxeberria J, Arnold M, Cai X, Hao Y, et al. (2023). Projections of Lung Cancer Incidence by 2035 in 40 Countries Worldwide: Population-Based Study. JMIR Public Health Surveill. 9(1):e43651. https://doi.org/10.2196/43651 PMID:36800235
44. Macciotta A, Catalano A, Giraudo MT, Weiderpass E, Ferrari P, Freisling H, et al. (2023). Mediating Role of Lifestyle Behaviors in the Association between Education and Cancer: Results from the European Prospective Investigation into Cancer and Nutrition. Cancer Epidemiol Biomarkers Prev. 32(1):132–40. https://doi.org/10.1158/1055-9965.EPI-22-0777 PMID:36306379
45. Mafra A, Bardot A, Charvat H, Weiderpass E, Soerjomataram I, Fregnani JHTG (2023). Cancer survival in the northwestern of São Paulo State, Brazil: A population-based study. Cancer Epidemiol. 83:102339. https://doi.org/10.1016/j.canep.2023.102339 PMID:36863216
46. Mallon B, Kaboré R, Couitchere L, Akonde FB, Narison MLR, Budiongo A, et al. (2023). The feasibility of implementing Toronto childhood cancer stage guidelines and estimating the impact on outcome for childhood cancers in seven pediatric oncology units in sub-Saharan Africa. A study from the Franco-African Pediatric Oncology Group. Pediatr Blood Cancer. 70(12):e30664. https://doi.org/10.1002/pbc.30664 PMID:37732944
47. Marant Micallef C, Charvat H, Houot MT, Vignat J, Straif K, Paul A, et al. (2023). Estimated number of cancers attributable to occupational exposures in France in 2017: an update using a new method for improved estimates. J Expo Sci Environ Epidemiol. 33(1):125–31. https://doi.org/10.1038/s41370-021-00353-1 PMID:34172838
48. Mohar, A., Paredes, A., Brau-Figueroa, H., Sanchez, A., Palafox, A., Rivera-Gomez, R., et al. (2023). [Not Available]. Salud Publica de México. 66(1, ene-feb): 104-112.
49. Morgan E, Arnold M, Gini A, Lorenzoni V, Cabasag CJ, Laversanne M, et al. (2023). Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN. Gut. 72(2):338–44. https://doi.org/10.1136/gutjnl-2022-327736 PMID:36604116
50. Morgan E, O’Neill C, Bardot A, Walsh P, Soerjomataram I, Arnold M (2023). The Challenges of Collecting Long-Term Outcomes in Cancer Patients on the Population-Level: The Case of Metastatic Breast Cancer. J Registry Manag. 50(4):173–5. PMID:38504704
51. Myklebust TA, Aagnes B, Nilssen Y, Rutherford M, Lambert PC, Andersson TML, et al. (2023). Improving communication of cancer survival statistics-feasibility of implementing model-based algorithms in routine publications. Br J Cancer. 129(5):819–28. https://doi.org/10.1038/s41416-023-02360-5 PMID:37433898
52. Ortega-Ortega M, Hanly P, Pearce A, Soerjomataram I, Sharp L (2023). Projected Impact on Labour Productivity Costs of Cancer-Related Premature Mortality in Europe 2018-2040. Appl Health Econ Health Policy. 21(6):877–89. https://doi.org/10.1007/s40258-023-00824-6 PMID:37552416
53. Piñeros M, Brierley J, Barrios E, Cueva P, Musetti C, Pardo C, et al. (2023). Accuracy of Essential TNM to stage large colorectal (T3/T4) cancers in absence of nodal status information. Acta Oncol. 62(12):1669–71. https://doi.org/10.1080/0284186X.2023.2257376 PMID:37738263
54. Ribeiro AG, Ferlay J, Vaccarella S, Latorre MDRDO, Fregnani JHTG, Bray F (2023). Thyroid Cancer Incidence and Mortality by Socioeconomic Level in the State of São Paulo, Brazil 2001-2017. Endocr Pract. 29(10):770–8. https://doi.org/10.1016/j.eprac.2023.07.028 PMID:37536501
55. Ribeiro AG, Ferlay J, Vaccarella S, Latorre MDRDO, Fregnani JHTG, Bray F (2023). Cancer inequalities in incidence and mortality in the State of São Paulo, Brazil 2001-17. Cancer Med. 12(15):16615–25. https://doi.org/10.1002/cam4.6259 PMID:37345901
56. Ritter J, Allen S, Cohen PD, Fajardo AF, Marx K, Loggetto P, et al. (2023). Financial hardship in families of children or adolescents with cancer: a systematic literature review. Lancet Oncol. 24(9):e364–75. https://doi.org/10.1016/S1470-2045(23)00320-0 PMID:37657477
57. Roshandel G, Badar F, Barchuk A, Roder DM, Sangrajrang S, Mery L, et al. (2023). REPCAN: Guideline for REporting Population-based CANcer Registry Data. Asian Pac J Cancer Prev. 24(9):3297–303. https://doi.org/10.31557/APJCP.2023.24.9.3297 PMID:37777857
58. Rumgay H, Cabasag CJ, Offman J, de Camargo Cancela M, Barchuk A, Mathur P, et al. (2023). International burden of cancer deaths and years of life lost from cancer attributable to four major risk factors: a population-based study in Brazil, Russia, India, China, South Africa, the United Kingdom, and United States. EClinicalMedicine. 66:102289. https://doi.org/10.1016/j.eclinm.2023.102289 PMID:38192589
59. Rumgay H, Ortega-Ortega M, Sharp L, Lunet N, Soerjomataram I (2023). The cost of premature death from cancer attributable to alcohol: Productivity losses in Europe in 2018. Cancer Epidemiol. 84:102365. https://doi.org/10.1016/j.canep.2023.102365 PMID:37058915
60. Sawant P, Perera S, Jayanthi KGN, Ziyad AIA, Saoba S, Ervik M, et al. (2023). Application of Rupantaran software to Sri Lankan hospitals: an innovative tool developed to merge population-based cancer registry data into CanReg5. Ecancermedicalscience. 17:1553. https://doi.org/10.3332/ecancer.2023.1553 PMID:37377679
61. Schmutz A, Matta M, Cairat M, Espina C, Schüz J, Kampman E, et al. (2023). Mapping the European cancer prevention research landscape: A case for more prevention research funding. Eur J Cancer. 195:113378. https://doi.org/10.1016/j.ejca.2023.113378 PMID:37924646
62. Schüz J, Espina C, Carvalho A, Maza M, Luciani S, Cazap E, et al. (2023). Latin America and the Caribbean Code Against Cancer 1st Edition: A landmark for cancer prevention in the region. Cancer Epidemiol. 86 Suppl 1:102453. https://doi.org/10.1016/j.canep.2023.102453 PMID:37852730
63. Schüz J, Ostroumova E, Kesminiene A, Davies L, Ahn HS, Togawa K, et al. (2023). Response to Toshihide Tsuda, Yumiko Miyano and Eiji Yamamoto [1]. Environ Health. 22(1):13. https://doi.org/10.1186/s12940-022-00952-x PMID:36703177
64. Sedeta E, Sung H, Laversanne M, Bray F, Jemal A (2023). Recent Mortality Patterns and Time Trends for the Major Cancers in 47 Countries Worldwide. Cancer Epidemiol Biomarkers Prev. 32(7):894–905. https://doi.org/10.1158/1055-9965.EPI-22-1133 PMID:37195435
65. Singh D, Vignat J, Lorenzoni V, Eslahi M, Ginsburg O, Lauby-Secretan B, et al. (2023). Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination Initiative. Lancet Glob Health. 11(2):e197–206. https://doi.org/10.1016/S2214-109X(22)00501-0 PMID:36528031
66. Soerjomataram I, Cabasag C, Bardot A, Fidler-Benaoudia MM, Miranda-Filho A, Ferlay J, et al.; SURVCAN-3 collaborators (2023). Cancer survival in Africa, central and south America, and Asia (SURVCAN-3): a population-based benchmarking study in 32 countries. Lancet Oncol. 24(1):22–32. https://doi.org/10.1016/S1470-2045(22)00704-5 PMID:36603919
67. Song CV, van Gils CH, Yip CH, Soerjomataram I, Taib NAM, See MH, et al. (2023). Discriminatory Ability and Clinical Utility of the AJCC7 and AJCC8 Staging Systems for Breast Cancer in a Middle-Income Setting. Diagnostics (Basel). 13(4):674. https://doi.org/10.3390/diagnostics13040674 PMID:36832162
68. Storm HH, Larønningen S, Bray F (2023). Do investments in cancer registry databases and tools bring added value? NORDCAN as an example. Acta Oncol. 62(6):535–40. https://doi.org/10.1080/0284186X.2023.2218557 PMID:37276272
69. Wéber A, Laversanne M, Nagy P, Kenessey I, Soerjomataram I, Bray F (2023). Gains in life expectancy from decreasing cardiovascular disease and cancer mortality – an analysis of 28 European countries 1995-2019. Eur J Epidemiol. 38(11):1141–52. https://doi.org/10.1007/s10654-023-01039-8 PMID:37676425
70. Wéber A, Mery L, Nagy P, Polgár C, Bray F, Kenessey I (2023). Evaluation of data quality at the Hungarian National Cancer Registry, 2000-2019. Cancer Epidemiol. 82:102306. https://doi.org/10.1016/j.canep.2022.102306 PMID:36521336
71. Wéber A, Morgan E, Vignat J, Laversanne M, Pizzato M, Rumgay H, et al. (2023). Lung cancer mortality in the wake of the changing smoking epidemic: a descriptive study of the global burden in 2020 and 2040. BMJ Open. 13(5):e065303. https://doi.org/10.1136/bmjopen-2022-065303 PMID:37164477
72. Wu L, Vaccarella S, Feng CY, Dal Maso L, Chen Y, Liu WW, et al. (2023). Mortality among papillary thyroid cancer patients by detection route: a hospital-based retrospective cohort study. Eur Thyroid J. 12(6):e230127. https://doi.org/10.1530/ETJ-23-0127 PMID:37855414
73. Xu J, Xu W, Choi J, Brhane Y, Christiani DC, Kothari J, et al. (2023). Large-scale whole exome sequencing studies identify two genes,CTSL and APOE, associated with lung cancer. PLoS Genet. 19(9):e1010902. https://doi.org/10.1371/journal.pgen.1010902 PMID:37738239
74. Youlden DR, Steliarova-Foucher E, Gini A, Silva NP, Aitken JFJ (2023). The growing prevalence of childhood cancer survivors in Australia. Pediatr Blood Cancer. 70(7):e30383. https://doi.org/10.1002/pbc.30383 PMID:37092826
75. Zhang Y, Rumgay H, Li M, Cao S, Chen W (2023). Nasopharyngeal Cancer Incidence and Mortality in 185 Countries in 2020 and the Projected Burden in 2040: Population-Based Global Epidemiological Profiling. JMIR Public Health Surveill. 9:e49968. https://doi.org/10.2196/49968 PMID:37728964
76. Zhang Y, Rumgay H, Li M, Yu H, Pan H, Ni J (2023). The global landscape of bladder cancer incidence and mortality in 2020 and projections to 2040. J Glob Health. 13:04109. https://doi.org/10.7189/jogh.13.04109 PMID:37712386
77. Zhang Y, Vaccarella S, Morgan E, Li M, Etxeberria J, Chokunonga E, et al. (2023). Global variations in lung cancer incidence by histological subtype in 2020: a population-based study. Lancet Oncol. 24(11):1206–18. https://doi.org/10.1016/S1470-2045(23)00444-8 PMID:37837979
78. Zheng R, Wang S, Zhang S, Zeng H, Chen R, Sun K, et al. (2023). Global, regional, and national lifetime probabilities of developing cancer in 2020. Sci Bull (Beijing). 68(21):2620–8. https://doi.org/10.1016/j.scib.2023.09.041 PMID:37821267
79. Znaor A, Ryzhov A, Losada ML, Carvalho A, Smelov V, Barchuk A, et al. (2023). Breast and cervical cancer screening practices in nine countries of Eastern Europe and Central Asia: A population-based survey. J Cancer Policy. 38:100436. https://doi.org/10.1016/j.jcpo.2023.100436 PMID:37544479
80. Zumsteg ZS, Luu M, Rosenberg PS, Elrod JK, Bray F, Vaccarella S, et al. (2023). Global epidemiologic patterns of oropharyngeal cancer incidence trends. J Natl Cancer Inst. 115(12):1544–54. https://doi.org/10.1093/jnci/djad169 PMID:37603716
81. Alkhalawi, E., Znaor, A., & Al-Zahrani, A. S. (2022). Quality of data from cancer registries in the Eastern Mediterranean region. Lancet Oncology. 23(4): 449-451. PMID: 35358450 https://doi.org/10.1016/S1470-2045(22)00072-9        
82. Andersson, T. M., Myklebust, T. A., Rutherford, M. J., Moller, B., Arnold, M., Soerjomataram, I., . . . Lambert, P. C. (2022). Five ways to improve international comparisons of cancer survival: lessons learned from ICBP SURVMARK-2. British Journal of Cancer. 126(8): 1224-1228. PMID: 35058590 https://doi.org/10.1038/s41416-022-01701-0               
83. Andersson, T. M., Rutherford, M. J., Myklebust, T. A., Moller, B., Arnold, M., Soerjomataram, I., . . . Lambert, P. C. (2022). A way to explore the existence of « immortals » in cancer registry data – An illustration using data from ICBP SURVMARK-2. Cancer Epidemiology. 76: 102085. PMID: 34954495 https://doi.org/10.1016/j.canep.2021.102085    
84. Araghi, M., Fidler-Benaoudia, M., Arnold, M., Rutherford, M., Bardot, A., Ferlay, J., . . . lung, I. C. C. L. c. C. (2022). International differences in lung cancer survival by sex, histological type and stage at diagnosis: an ICBP SURVMARK-2 Study. Thorax. 77(4): 378-390. PMID: 34282033 https://doi.org/10.1136/thoraxjnl-2020-216555          
85. Arnold, M., Morgan, E., Bardot, A., Rutherford, M. J., Ferlay, J., Little, A., . . . Soerjomataram, I. (2022). International variation in oesophageal and gastric cancer survival 2012-2014: differences by histological subtype and stage at diagnosis (an ICBP SURVMARK-2 population-based study). Gut. 71(8): 1532-1543. PMID: 34824149 https://doi.org/10.1136/gutjnl-2021-325266      
86. Arnold, M., Morgan, E., Rumgay, H., Mafra, A., Singh, D., Laversanne, M., . . . Soerjomataram, I. (2022). Current and future burden of breast cancer: Global statistics for 2020 and 2040. Breast. 66: 15-23. PMID: 36084384 https://doi.org/10.1016/j.breast.2022.08.010    
87. Arnold, M., Morgan, E., Rumgay, H., Mafra, A., Singh, D., Laversanne, M., . . . Soerjomataram, I. (2022). Current and future burden of breast cancer: Global statistics for 2020 and 2040. Breast. 66: 15-23. PMID: 36084384 https://doi.org/10.1016/j.breast.2022.08.010    
88. Arnold, M., Singh, D., Laversanne, M., Vignat, J., Vaccarella, S., Meheus, F., . . . Bray, F. (2022). Global Burden of Cutaneous Melanoma in 2020 and Projections to 2040. JAMA Dermatol. 158(5): 495-503. PMID: 35353115 https://doi.org/10.1001/jamadermatol.2022.0160           
89. Banack, H. R., Chang, J., Stefanick, M. L., Arnold, M., Anton-Culver, H., & Jiang, L. (2022). Relationship between BMI trajectories and cardiometabolic outcomes in postmenopausal women: a growth mixture modeling approach. Annals of Epidemiology. 72: 9-17. PMID: 35469929 https://doi.org/10.1016/j.annepidem.2022.04.004          
90. Bravo, L. E., Garcia, L. S., Collazos, P., Holguin, J., Soerjomataram, I., & Miranda-Filho, A. (2022). Trends in long-term cancer survival in Cali, Colombia: 1998-2017. Colomb Med (Cali). 53(1): e2035082. PMID: 36452118 https://doi.org/10.25100/cm.v53i1.5082             
91. Bravo, L. E., Garcia, L. S., Collazos, P., Holguin, J., Soerjomataram, I., & Miranda-Filho, A. (2022). Trends in long-term cancer survival in Cali, Colombia: 1998-2017. Colomb Med (Cali). 53(1): e2035082. PMID: 36452118 https://doi.org/10.25100/cm.v53i1.5082             
92. Bray, F., Parkin, D. M., & African Cancer Registry, N. (2022). Cancer in sub-Saharan Africa in 2020: a review of current estimates of the national burden, data gaps, and future needs. Lancet Oncology. 23(6): 719-728. PMID: 35550275 https://doi.org/10.1016/S1470-2045(22)00270-4             
93. Bukavina, L., Bensalah, K., Bray, F., Carlo, M., Challacombe, B., Karam, J. A., . . . Psutka, S. P. (2022). Epidemiology of Renal Cell Carcinoma: 2022 Update. European Urology. 82(5): 529-542. PMID: 36100483 https://doi.org/10.1016/j.eururo.2022.08.019
94. Byrne, J., Schmidtmann, I., Rashid, H., Hagberg, O., Bagnasco, F., Bardi, E., . . . Grabow, D. (2022). Impact of era of diagnosis on cause-specific late mortality among 77 423 five-year European survivors of childhood and adolescent cancer: The PanCareSurFup consortium. International Journal of Cancer. 150(3): 406-419. PMID: 34551126 https://doi.org/10.1002/ijc.33817           
95. Cabasag, C. J., Arnold, M., Rutherford, M., Bardot, A., Ferlay, J., Morgan, E., . . . Soerjomataram, I. (2022). Pancreatic cancer survival by stage and age in seven high-income countries (ICBP SURVMARK-2): a population-based study. British Journal of Cancer. 126(12): 1774-1782. PMID: 35236937 https://doi.org/10.1038/s41416-022-01752-3              
96. Cabasag, C. J., Fagan, P. J., Ferlay, J., Vignat, J., Laversanne, M., Liu, L., . . . Soerjomataram, I. (2022). Ovarian cancer today and tomorrow: A global assessment by world region and Human Development Index using GLOBOCAN 2020. International Journal of Cancer. 151(9): 1535-1541. PMID: 35322413 https://doi.org/10.1002/ijc.34002  
97. Cabasag, C. J., Ferlay, J., Laversanne, M., Vignat, J., Weber, A., Soerjomataram, I., & Bray, F. (2022). Pancreatic cancer: an increasing global public health concern. Gut. 71(8): 1686-1687. PMID: 34686577 https://doi.org/10.1136/gutjnl-2021-326311  
98. Cabasag, C. J., Vignat, J., Ferlay, J., Arndt, V., Lemmens, V., Praagman, J., . . . Soerjomataram, I. (2022). The preventability of cancer in Europe: A quantitative assessment of avoidable cancer cases across 17 cancer sites and 38 countries in 2020. European Journal of Cancer. 177: 15-24. PMID: 36323048 https://doi.org/10.1016/j.ejca.2022.09.030         
99. Carle, C., Hughes, S., Freeman, V., Campbell, D., Egger, S., Caruana, M., . . . Steinberg, J. (2022). The risk of contracting SARS-CoV-2 or developing COVID-19 for people with cancer: A systematic review of the early evidence. J Cancer Policy. 33: 100338. PMID: 35671919 https://doi.org/10.1016/j.jcpo.2022.100338  
100. Chargari, C., Arbyn, M., Leary, A., Abu-Rustum, N. R., Basu, P., Bray, F., . . . Morice, P. (2022). Increasing global accessibility to high-level treatments for cervical cancers. Gynecologic Oncology. 164(1): 231-241. PMID: 34716024 https://doi.org/10.1016/j.ygyno.2021.10.073     
101. Charvat, H., Freisling, H., Noh, H., Gaudet, M. M., Gunter, M. J., Cross, A. J., . . . Arnold, M. (2022). Excess Body Fatness during Early to Mid-Adulthood and Survival from Colorectal and Breast Cancer: A Pooled Analysis of Five International Cohort Studies. Cancer Epidemiology, Biomarkers and Prevention. 31(2): 325-333. PMID: 34782393 https://doi.org/10.1158/1055-9965.EPI-21-0688              
102. de Camargo Cancela, M., de Oliveira Santos, M., Migowski, A., & Pineros, M. (2022). Breast cancer among young women in Brazil: Differences between hospital and population-based series. Cancer Epidemiology. 79: 102193. PMID: 35696767 https://doi.org/10.1016/j.canep.2022.102193    
103. Dee, E. C., Eala, M. A. B., Chua, M. L. K., Bray, F., & Bhoo-Pathy, N. (2022). Adolescents and young adults with cancer: Considerations from the Southeast Asian perspective. Pediatric Blood & Cancer. 69(7): e29593. PMID: 35129873 https://doi.org/10.1002/pbc.29593        
104. Dee, E. C., Santos, P. M. G., & Bray, F. (2022). The shifting epidemiology of lung cancer in Asian and Asian diaspora populations: Implications for clinical and global health policy research. Asia-Pacific Journal of Clinical Oncology. 18(5): e524-e525. PMID: 35098661 https://doi.org/10.1111/ajco.13738   
105. Doganis, D., Karalexi, M. A., group, N.-S. c., Panagopoulou, P., Bouka, P., Bouka, E., . . . Petridou, E. T. (2022). Incidence patterns of childhood non-Wilms renal tumors: Comparing data of the Nationwide Registry of Childhood Hematological Malignancies and Solid Tumors (NARECHEM-ST), Greece, and the Surveillance, Epidemiology, and End Results Program (SEER), USA. Cancer Epidemiology. 78: 102153. PMID: 35390585 https://doi.org/10.1016/j.canep.2022.102153
106. Freeman, V., Hughes, S., Carle, C., Campbell, D., Egger, S., Hui, H., . . . Canfell, K. (2022). Are patients with cancer at higher risk of COVID-19-related death? A systematic review and critical appraisal of the early evidence. J Cancer Policy. 33: 100340. PMID: 35680113 https://doi.org/10.1016/j.jcpo.2022.100340  
107. Gil, F., Miranda-Filho, A., Uribe-Perez, C., Arias-Ortiz, N. E., Yepez-Chamorro, M. C., Bravo, L. M., & de Vries, E. (2022). Impact of the Management and Proportion of Lost to Follow-Up Cases on Cancer Survival Estimates for Small Population-Based Cancer Registries. Journal of Cancer Epidemiology. 2022: 9068214. PMID: 35140789 https://doi.org/10.1155/2022/9068214
108. Gini, A., & Selby, K. (2022). Fecal Immunochemical Tests: The Right Colorectal Cancer Screening Test for the Average-Risk Population? Clinical Gastroenterology and Hepatology. 20(10): 2216-2217. PMID: 35390510 https://doi.org/10.1016/j.cgh.2022.03.030          
109. Guida, F., Kidman, R., Ferlay, J., Schuz, J., Soerjomataram, I., Kithaka, B., . . . McCormack, V. (2022). Global and regional estimates of orphans attributed to maternal cancer mortality in 2020. Nature Medicine. 28(12): 2563-2572. PMID: 36404355 https://doi.org/10.1038/s41591-022-02109-2    
110. Hanly, P., Ortega-Ortega, M., & Soerjomataram, I. (2022). Cancer Premature Mortality Costs in Europe in 2020: A Comparison of the Human Capital Approach and the Friction Cost Approach. Current Oncology (Toronto, Ont.). 29(5): 3552-3564. PMID: 35621677 https://doi.org/10.3390/curroncol29050287  
111. Ibrahim Khalil, A., Franceschi, S., de Martel, C., Bray, F., & Clifford, G. M. (2022). Burden of Kaposi sarcoma according to HIV status: A systematic review and global analysis. International Journal of Cancer. 150(12): 1948-1957. PMID: 35085400 https://doi.org/10.1002/ijc.33951           
112. Ibrahim Khalil, A., Mpunga, T., Wei, F., Baussano, I., de Martel, C., Bray, F., . . . Clifford, G. M. (2022). Age-specific burden of cervical cancer associated with HIV: A global analysis with a focus on sub-Saharan Africa. International Journal of Cancer. 150(5): 761-772. PMID: 34626498 https://doi.org/10.1002/ijc.33841         
113. Ilbawi, A. M., Lam, C. G., Ortiz, R., & Bray, F. (2022). Investing in childhood cancer registries to drive progress. Lancet Child Adolesc Health. 6(7): 446-447. PMID: 35605627 https://doi.org/10.1016/S2352-4642(22)00148-1             
114. Kenessey, I., Szoke, G., Dobozi, M., Szatmari, I., Weber, A., Fogarassy, G., . . . Vathy-Fogarassy, A. (2022). Comparison of Cancer Survival Trends in Hungary in the Periods 2001-2005 and 2011-2015 According to a Population-Based Cancer Registry. Pathology Oncology Research. 28: 1610668. PMID: 36147657 https://doi.org/10.3389/pore.2022.1610668      
115. Kiss, Z., Wittmann, I., Polivka, L., Surjan, G., Surjan, O., Barcza, Z., . . . Voko, Z. (2022). Nationwide Effectiveness of First and Second SARS-CoV2 Booster Vaccines During the Delta and Omicron Pandemic Waves in Hungary (HUN-VE 2 Study). Frontiers in Immunology. 13: 905585. PMID: 35812442 https://doi.org/10.3389/fimmu.2022.905585     
116. Kiss, Z. N., Bogos, K., Tamasi, L., Ostoros, G., Muller, V., Bittner, N., . . . Polanyi, Z. (2022). Underlying reasons for post-mortem diagnosed lung cancer cases – A robust retrospective comparative study from Hungary (HULC study). Frontiers in Oncology. 12: 1032366. PMID: 36505881 https://doi.org/10.3389/fonc.2022.1032366         
117. Kohls, M., Freisling, H., Charvat, H., Soerjomataram, I., Viallon, V., Davila-Batista, V., . . . Arnold, M. (2022). Impact of cumulative body mass index and cardiometabolic diseases on survival among patients with colorectal and breast cancer: a multi-centre cohort study. BMC Cancer. 22(1): 546. PMID: 35568802 https://doi.org/10.1186/s12885-022-09589-y    
118. Leal, Y. A., Torres, J., Gamboa, R., Mantilla-Morales, A., Pina-Sanchez, P., Arrieta, O., . . . Pineros, M. (2022). Cancer Incidence in Merida, Mexico 2015-2018: First Report from the Population-based Cancer Registry. Archives of Medical Research. 53(8): 859-866. PMID: 36462950 https://doi.org/10.1016/j.arcmed.2022.11.015            
119. Li, M., Zhang, L., Charvat, H., Callister, M. E., Sasieni, P., Christodoulou, E., . . . Robbins, H. A. (2022). The influence of postscreening follow-up time and participant characteristics on estimates of overdiagnosis from lung cancer screening trials. International Journal of Cancer. 151(9): 1491-1501. PMID: 35809038 https://doi.org/10.1002/ijc.34167           
120. Lorenzoni, V., Chaturvedi, A. K., Vignat, J., Laversanne, M., Bray, F., & Vaccarella, S. (2022). The Current Burden of Oropharyngeal Cancer: A Global Assessment Based on GLOBOCAN 2020. Cancer Epidemiology, Biomarkers and Prevention. 31(11): 2054-2062. PMID: 36173880 https://doi.org/10.1158/1055-9965.EPI-22-0642
121. Luo, Q., Lew, J. B., Steinberg, J., Worthington, J., Yu, X. Q., Caruana, M., . . . Feletto, E. (2022). Trends in colon and rectal cancer mortality in Australia from 1972 to 2015 and associated projections to 2040. Scientific Reports. 12(1): 3994. PMID: 35256697 https://doi.org/10.1038/s41598-022-07797-x     
122. Luo, Q., O’Connell, D. L., Yu, X. Q., Kahn, C., Caruana, M., Pesola, F., . . . Canfell, K. (2022). Cancer incidence and mortality in Australia from 2020 to 2044 and an exploratory analysis of the potential effect of treatment delays during the COVID-19 pandemic: a statistical modelling study. Lancet Public Health. 7(6): e537-e548. PMID: 35660215 https://doi.org/10.1016/S2468-2667(22)00090-1             
123. Mafra, A., Laversanne, M., Gospodarowicz, M., Klinger, P., De Paula Silva, N., Pineros, M., . . . Znaor, A. (2022). Global patterns of non-Hodgkin lymphoma in 2020. International Journal of Cancer. 151(9): 1474-1481. PMID: 35695282 https://doi.org/10.1002/ijc.34163           
124. Mafra da Costa, A., Hernandes, I. C. P., Weiderpass, E., Soerjomataram, I., & Fregnani, J. (2022). Cancer Statistics over Time in Northwestern Sao Paulo State, Brazil: Incidence and Mortality. Cancer Epidemiology, Biomarkers and Prevention. 31(4): 707-714. PMID: 35131883 https://doi.org/10.1158/1055-9965.EPI-21-0842         
125. Malakova, K., Cabasag, C. J., Bardot, A., Sangrajrang, S., Chitapanarux, I., Sripan, P., . . . Soerjomataram, I. (2022). Cancer survival in Thailand from 1997 to 2012: Assessing the impact of universal health coverage. J Cancer Policy. 34: 100353. PMID: 36357312 https://doi.org/10.1016/j.jcpo.2022.100353  
126. Morgan, E., Arnold, M., Camargo, M. C., Gini, A., Kunzmann, A. T., Matsuda, T., . . . Soerjomataram, I. (2022). The current and future incidence and mortality of gastric cancer in 185 countries, 2020-40: A population-based modelling study. EClinicalMedicine. 47: 101404. PMID: 35497064 https://doi.org/10.1016/j.eclinm.2022.101404   
127. Morgan, E., Soerjomataram, I., Rumgay, H., Coleman, H. G., Thrift, A. P., Vignat, J., . . . Arnold, M. (2022). The Global Landscape of Esophageal Squamous Cell Carcinoma and Esophageal Adenocarcinoma Incidence and Mortality in 2020 and Projections to 2040: New Estimates From GLOBOCAN 2020. Gastroenterology. 163(3): 649-658 e642. PMID: 35671803 https://doi.org/10.1053/j.gastro.2022.05.054      
128. Nemati, S., Saeedi, E., Lotfi, F., Nahvijou, A., Mohebbi, E., Ravankhah, Z., . . . Zendehdel, K. (2022). National surveillance of cancer survival in Iran (IRANCANSURV): Analysis of data of 15 cancer sites from nine population-based cancer registries. International Journal of Cancer. 151(12): 2128-2135. PMID: 35869869 https://doi.org/10.1002/ijc.34224           
129. Nemati, S., Saeedi, E., Roshandel, G., Nahvijou, A., Badakhshan, A., Akbari, M., . . . Zendehdel, K. (2022). Population-based cancer survival in the Golestan province in the northeastern part of Iran 2007-2012. Cancer Epidemiology. 77: 102089. PMID: 35042146 https://doi.org/10.1016/j.canep.2021.102089              
130. Noll, F., Adams, T., Cohen, R., Soerjomataram, I., & Reid, F. (2022). Building opportunities to improve quality of life for women with ovarian cancer in low- and middle-income countries: the Every Woman Study. International Journal of Gynecological Cancer. 32(8): 1080-1081. PMID: 35314459 https://doi.org/10.1136/ijgc-2022-003449    
131. Ortega-Ortega, M., Hanly, P., Pearce, A., Soerjomataram, I., & Sharp, L. (2022). Paid and unpaid productivity losses due to premature mortality from cancer in Europe in 2018. International Journal of Cancer. 150(4): 580-593. PMID: 34569617 https://doi.org/10.1002/ijc.33826           
132. Pastorino, R., Sassano, M., Danilo Tiziano, F., Giraldi, L., Amore, R., Arzani, D., . . . Boccia, S. (2022). Plasma miR-151-3p as a Candidate Diagnostic Biomarker for Head and Neck Cancer: A Cross-sectional Study within the INHANCE Consortium. Cancer Epidemiology, Biomarkers and Prevention. 31(12): 2237-2243. PMID: 36126276 https://doi.org/10.1158/1055-9965.EPI-22-0376              
133. Payne, N. W. S., Brown, K. F., Delon, C., Kotrotsios, Y., Soerjomataram, I., & Shelton, J. (2022). Socio-economic deprivation and cancer incidence in England: Quantifying the role of smoking. PloS One. 17(9): e0272202. PMID: 36129905 https://doi.org/10.1371/journal.pone.0272202
134. Persson, M. S. M., Yin, W., Doring, N., Risnes, K., Weiderpass, E., Steliarova-Foucher, E., & Sandin, S. (2022). Gestational age and cancer risk up to young adulthood in Swedish population born 1974 to 2013: A population-based cohort study. International Journal of Cancer. 150(8): 1269-1280. PMID: 34855204 https://doi.org/10.1002/ijc.33886           
135. Pierannunzio, D., Fedeli, U., Francisci, S., Paoli, A., Toffolutti, F., Serraino, D., . . . Dal Maso, L. (2022). Thyroidectomies in Italy: A Population-Based National Analysis from 2001 to 2018. Thyroid. 32(3): 263-272. PMID: 35018816 https://doi.org/10.1089/thy.2021.0531
136. Pilleron, S., Alqurini, N., Ferlay, J., Haase, K. R., Hannan, M., Janssen-Heijnen, M., . . . Morris, E. J. A. (2022). International trends in cancer incidence in middle-aged and older adults in 44 countries. Journal of Geriatric Oncology. 13(3): 346-355. PMID: 34866023 https://doi.org/10.1016/j.jgo.2021.11.011      
137. Pinello, K., Baldassarre, V., Steiger, K., Paciello, O., Pires, I., Laufer-Amorim, R., . . . Dagli, M. L. Z. (2022). Vet-ICD-O-Canine-1, a System for Coding Canine Neoplasms Based on the Human ICD-O-3.2. Cancers. 14(6). PMID: 35326681 https://doi.org/10.3390/cancers14061529          
138. Pineros, M. (2022). Evaluation and variability of quality in mortality statistics in Colombia: the importance of detail. REVISTA COLOMBIANA DE CANCEROLOGIA. 26(3): 241-243. PMID:   
139. Pineros, M., Ginsburg, O., Bendahhou, K., Eser, S., Shelpai, W. A., Fouad, H., . . . Staging Survey, G. (2022). Staging practices and breast cancer stage among population-based registries in the MENA region. Cancer Epidemiology. 81: 102250. PMID: 36115143 https://doi.org/10.1016/j.canep.2022.102250              
140. Pineros, M., Laversanne, M., Barrios, E., Cancela, M. C., de Vries, E., Pardo, C., & Bray, F. (2022). An updated profile of the cancer burden, patterns and trends in Latin America and the Caribbean. Lancet Reg Health Am. 13: None. PMID: 36189115 https://doi.org/10.1016/j.lana.2022.100294       
141. Pizzato, M., Li, M., Vignat, J., Laversanne, M., Singh, D., La Vecchia, C., & Vaccarella, S. (2022). The epidemiological landscape of thyroid cancer worldwide: GLOBOCAN estimates for incidence and mortality rates in 2020. Lancet Diabetes and Endocrinology. 10(4): 264-272. PMID: 35271818 https://doi.org/10.1016/S2213-8587(22)00035-3            
142. Pizzato, M., Martinsen, J. I., Heikkinen, S., Vignat, J., Lynge, E., Sparen, P., . . . Vaccarella, S. (2022). Socioeconomic status and risk of lung cancer by histological subtype in the Nordic countries. Cancer Med. 11(8): 1850-1859. PMID: 35166068 https://doi.org/10.1002/cam4.4548       
143. Roel, E., Pistillo, A., Recalde, M., Fernandez-Bertolin, S., Aragon, M., Soerjomataram, I., . . . Duarte-Salles, T. (2022). Cancer and the risk of coronavirus disease 2019 diagnosis, hospitalisation and death: A population-based multistate cohort study including 4 618 377 adults in Catalonia, Spain. International Journal of Cancer. 150(5): 782-794. PMID: 34655476 https://doi.org/10.1002/ijc.33846         
144. Rumgay, H., Arnold, M., Ferlay, J., Lesi, O., Cabasag, C. J., Vignat, J., . . . Soerjomataram, I. (2022). Global burden of primary liver cancer in 2020 and predictions to 2040. Journal of Hepatology. 77(6): 1598-1606. PMID: 36208844 https://doi.org/10.1016/j.jhep.2022.08.021        
145. Rumgay, H., Ferlay, J., de Martel, C., Georges, D., Ibrahim, A. S., Zheng, R., . . . Soerjomataram, I. (2022). Global, regional and national burden of primary liver cancer by subtype. European Journal of Cancer. 161: 108-118. PMID: 34942552 https://doi.org/10.1016/j.ejca.2021.11.023         
146. Sarich, P., Cabasag, C. J., Liebermann, E., Vaneckova, P., Carle, C., Hughes, S., . . . Soerjomataram, I. (2022). Tobacco smoking changes during the first pre-vaccination phases of the COVID-19 pandemic: A systematic review and meta-analysis. EClinicalMedicine. 47: 101375. PMID: 35434579 https://doi.org/10.1016/j.eclinm.2022.101375   
147. Singh, D., Vaccarella, S., Gini, A., De Paula Silva, N., Steliarova-Foucher, E., & Bray, F. (2022). Global patterns of Hodgkin lymphoma incidence and mortality in 2020 and a prediction of the future burden in 2040. International Journal of Cancer. 150(12): 1941-1947. PMID: 35080783 https://doi.org/10.1002/ijc.33948
148. Smith, L., Stiller, C. A., Aitken, J. F., Hjalgrim, L. L., Johannesen, T., Lahteenmaki, P., . . . Feltbower, R. G. (2022). International variation in childhood cancer mortality rates from 2001 to 2015: Comparison of trends in the International Cancer Benchmarking Partnership countries. International Journal of Cancer. 150(1): 28-37. PMID: 34449879 https://doi.org/10.1002/ijc.33774      
149. Soerjomataram, I., Bardot, A., Aitken, J., Pineros, M., Znaor, A., Steliarova-Foucher, E., . . . Bray, F. (2022). Impact of the COVID-19 pandemic on population-based cancer registry. International Journal of Cancer. 150(2): 273-278. PMID: 34480348 https://doi.org/10.1002/ijc.33792           
150. Soerjomataram, I., Bray, F., Lansdorp-Vogelaar, I., Ginsburg, O., Rahal, R., Sullivan, R., . . . Cancer Global Modelling, C. (2022). COVID-19 and Cancer Global Modelling Consortium (CCGMC): A global reference to inform national recovery strategies. J Cancer Policy. 32: 100328. PMID: 35560265 https://doi.org/10.1016/j.jcpo.2022.100328       
151. Soo, R., Mery, L., Bardot, A., Kanesvaran, R., Keong, T. C., Pongnikorn, D., . . . Stahel, R. (2022). Diagnostic work-up and systemic treatment for advanced non-squamous non-small-cell lung cancer in four Southeast Asian countries. ESMO Open. 7(5): 100560. PMID: 35988454 https://doi.org/10.1016/j.esmoop.2022.100560           
152. Voko, Z., Kiss, Z., Surjan, G., Surjan, O., Barcza, Z., Wittmann, I., . . . Kasler, M. (2022). Effectiveness and Waning of Protection With Different SARS-CoV-2 Primary and Booster Vaccines During the Delta Pandemic Wave in 2021 in Hungary (HUN-VE 3 Study). Frontiers in Immunology. 13: 919408. PMID: 35935993 https://doi.org/10.3389/fimmu.2022.919408     
153. Wang, S., Zheng, R., Arnold, M., Abnet, C., Zeng, H., Zhang, S., . . . He, J. (2022). Global and national trends in the age-specific sex ratio of esophageal cancer and gastric cancer by subtype. International Journal of Cancer. 151(9): 1447-1461. PMID: 35678331 https://doi.org/10.1002/ijc.34158           
154. Weber, A., Szatmari, I., Dobozi, M., Hilbert, L., Branyiczkine Geczy, G., Nagy, P., . . . Kenessey, I. (2022). [Comparison of Hungarian Central Statistical Office’s causes of death data with the database of the Hungarian National Cancer Registry]. Orvosi Hetilap. 163(37): 1481-1489. PMID: 36088625 https://doi.org/10.1556/650.2022.32573
155. Withrow, D., Pilleron, S., Nikita, N., Ferlay, J., Sharma, S., Nicholson, B., . . . Lu-Yao, G. (2022). Current and projected number of years of life lost due to prostate cancer: A global study. Prostate. 82(11): 1088-1097. PMID: 35468227 https://doi.org/10.1002/pros.24360       
156. Znaor, A., Corbex, M., Cao, B., Laversanne, M., Ryzhov, A., Smelov, V., & Bray, F. (2022). Progress in reducing premature mortality from cancer and cardiovascular disease in the former Soviet Union, 2000-19. European Journal of Public Health. 32(4): 624-629. PMID: 35441219 https://doi.org/10.1093/eurpub/ckac030
157. Znaor, A., Skakkebaek, N. E., Rajpert-De Meyts, E., Kulis, T., Laversanne, M., Gurney, J., . . . Bray, F. (2022). Global patterns in testicular cancer incidence and mortality in 2020. International Journal of Cancer. 151(5): 692-698. PMID: 35277970 https://doi.org/10.1002/ijc.33999           
158. Amosa-Lei Sam, F., Akinremi, A., Mery, L., Sarfati, D., Stanley, J., & Gurney, J. (2021). Cancer Incidence in Samoa: A 10-Year Retrospective Survey (2007-2016). Asia Pac J Public Health. 33(6-7): 700-706. PMID: 33233921  doi: 10.1177/1010539520975261
159. Andersson, T. M., Myklebust, T. A., Rutherford, M. J., Moller, B., Soerjomataram, I., Arnold, M., . . . Lambert, P. C. (2021). The impact of excluding or including Death Certificate Initiated (DCI) cases on estimated cancer survival: A simulation study. Cancer Epidemiol. 71(Pt A): 101881. PMID: 33440295  doi: 10.1016/j.canep.2020.101881
160. Andersson, T. M., Rutherford, M. J., Myklebust, T. A., Moller, B., Soerjomataram, I., Arnold, M., . . . Lambert, P. C. (2021). Exploring the impact of cancer registry completeness on international cancer survival differences: a simulation study. Br J Cancer. 124(5): 1026-1032. PMID: 33293692  doi: 10.1038/s41416-020-01196-7
161. Araghi, M., Arnold, M., Rutherford, M. J., Guren, M. G., Cabasag, C. J., Bardot, A., . . . Soerjomataram, I. (2021). Colon and rectal cancer survival in seven high-income countries 2010-2014: variation by age and stage at diagnosis (the ICBP SURVMARK-2 project). Gut. 70(1): 114-126. PMID: 32482683  doi: 10.1136/gutjnl-2020-320625
162. Arbyn, M., Gultekin, M., Morice, P., Nieminen, P., Cruickshank, M., Poortmans, P., . . . Weiderpass, E. (2021). The European response to the WHO call to eliminate cervical cancer as a public health problem. Int J Cancer. 148(2): 277-284. PMID: 32638362  doi: 10.1002/ijc.33189
163. Barchuk, A., Belyaev, A., Gretsova, O., Tursun-Zade, R., Moshina, N., & Znaor, A. (2021). History and current status of cancer registration in Russia. Cancer Epidemiol. 73: 101963. PMID: 34089992  doi: 10.1016/j.canep.2021.101963
164. Barchuk, A., Tursun-Zade, R., Belayev, A., Moore, M., Komarov, Y., Moshina, N., . . . Znaor, A. (2021). Comparability and validity of cancer registry data in the northwest of Russia. Acta Oncol. 60(10): 1264-1271. PMID: 34424113  doi: 10.1080/0284186X.2021.1967443
165. Bonjour, M., Charvat, H., Franco, E. L., Pineros, M., Clifford, G. M., Bray, F., & Baussano, I. (2021). Global estimates of expected and preventable cervical cancers among girls born between 2005 and 2014: a birth cohort analysis. Lancet Public Health. 6(7): e510-e521. PMID: 33864738  doi: 10.1016/S2468-2667(21)00046-3
166. Bray, F., Laversanne, M., Cao, B., Varghese, C., Mikkelsen, B., Weiderpass, E., & Soerjomataram, I. (2021). Comparing cancer and cardiovascular disease trends in 20 middle- or high-income countries 2000-19: A pointer to national trajectories towards achieving Sustainable Development goal target 3.4. Cancer Treat Rev. 100: 102290. PMID: 34536729  doi: 10.1016/j.ctrv.2021.102290
167. Bray, F., Laversanne, M., Weiderpass, E., & Soerjomataram, I. (2021). The ever-increasing importance of cancer as a leading cause of premature death worldwide. Cancer. 127(16): 3029-3030. PMID: 34086348  doi: 10.1002/cncr.33587
168. Bukirwa, P., Wabinga, H., Nambooze, S., Amulen, P. M., Joko, W. Y., Liu, B., & Parkin, D. M. (2021). Trends in the incidence of cancer in Kampala, Uganda, 1991 to 2015. Int J Cancer. 148(9): 2129-2138. PMID: 33129228  doi: 10.1002/ijc.33373
169. Cabasag, C. J., Arnold, M., Pineros, M., Morgan, E., Brierley, J., Hofferkamp, J., . . . Parkin, D. M. (2021). Population-based cancer staging for oesophageal, gastric, and pancreatic cancer 2012-2014: International Cancer Benchmarking Partnership SurvMark-2. Int J Cancer. 149(6): 1239-1246. PMID: 33990959  doi: 10.1002/ijc.33679
170. Conway, D. I., Hovanec, J., Ahrens, W., Ross, A., Holcatova, I., Lagiou, P., . . . McMahon, A. D. (2021). Occupational socioeconomic risk associations for head and neck cancer in Europe and South America: individual participant data analysis of pooled case-control studies within the INHANCE Consortium. J Epidemiol Community Health. 75(8): 779-787. PMID: 33622804  doi: 10.1136/jech-2020-214913
171. Crocetti, E., Mattioli, V., Buzzoni, C., Franceschi, S., Serraino, D., Vaccarella, S., . . . for, A. w. g. (2021). Risk of thyroid as a first or second primary cancer. A population-based study in Italy, 1998-2012. Cancer Med. 10(19): 6855-6867. PMID: 34533289  doi: 10.1002/cam4.4193
172. Dal Maso, L., Panato, C., De Paoli, A., Mattioli, V., Serraino, D., Elisei, R., . . . Group, D. W. (2021). Trends in thyroid function testing, neck ultrasound, thyroid fine needle aspiration, and thyroidectomies in North-eastern Italy. J Endocrinol Invest. 44(8): 1679-1688. PMID: 33460012  doi: 10.1007/s40618-020-01475-3
173. Duggan, C., Trapani, D., Ilbawi, A. M., Fidarova, E., Laversanne, M., Curigliano, G., . . . Anderson, B. O. (2021). National health system characteristics, breast cancer stage at diagnosis, and breast cancer mortality: a population-based analysis. Lancet Oncol. 22(11): 1632-1642. PMID: 34653370  doi: 10.1016/S1470-2045(21)00462-9
174. Dyba, T., Randi, G., Bray, F., Martos, C., Giusti, F., Nicholson, N., . . . Bettio, M. (2021). The European cancer burden in 2020: Incidence and mortality estimates for 40 countries and 25 major cancers. Eur J Cancer. 157: 308-347. PMID: 34560371  doi: 10.1016/j.ejca.2021.07.039
175. Ferlay, J., Colombet, M., Soerjomataram, I., Parkin, D. M., Pineros, M., Znaor, A., & Bray, F. (2021). Cancer statistics for the year 2020: An overview. Int J Cancer. 149(4): 778-789. PMID: 33818764  doi: 10.1002/ijc.33588
176. Gandaglia, G., Leni, R., Bray, F., Fleshner, N., Freedland, S. J., Kibel, A., . . . La Vecchia, C. (2021). Epidemiology and Prevention of Prostate Cancer. Eur Urol Oncol. 4(6): 877-892. PMID: 34716119  doi: 10.1016/j.euo.2021.09.006
177. Genere, N., El Kawkgi, O. M., Giblon, R. E., Vaccarella, S., Morris, J. C., Hay, I. D., & Brito, J. P. (2021). Incidence of Clinically Relevant Thyroid Cancers Remains Stable for Almost a Century: A Population-Based Study. Mayo Clin Proc. 96(11): 2823-2830. PMID: 34736609  doi: 10.1016/j.mayocp.2021.04.028
178. Gredner, T., Mons, U., Niedermaier, T., Brenner, H., & Soerjomataram, I. (2021). Impact of tobacco control policies implementation on future lung cancer incidence in Europe: An international, population-based modeling study. Lancet Reg Health Eur. 4: 100074. PMID: 34029359  doi: 10.1016/j.lanepe.2021.100074
179. Gullickson, C., Goodman, M., Joko-Fru, Y. W., Gnangnon, F. H. R., N’Da, G., Woldegeorgis, M. A., . . . Jemal, A. (2021). Colorectal cancer survival in sub-Saharan Africa by age, stage at diagnosis and Human Development Index: A population-based registry study. Int J Cancer. 149(8): 1553-1563. PMID: 34164808  doi: 10.1002/ijc.33715
180. Johnson, S., Tittenbrun, Z., Romero, Y., Torode, J., Frech, S., Abdel-Wahab, M., . . . Mikkelsen, B. (2021). The World Cancer Declaration: time to consolidate wins and work towards 2025. Lancet Oncol. 22(3): 296-298. PMID: 33548178  doi: 10.1016/S1470-2045(21)00012-7
181. Johnston, W. T., Erdmann, F., Newton, R., Steliarova-Foucher, E., Schuz, J., & Roman, E. (2021). Childhood cancer: Estimating regional and global incidence. Cancer Epidemiol. 71(Pt B): 101662. PMID: 31924557  doi: 10.1016/j.canep.2019.101662
182. Kilian, C., Rovira, P., Neufeld, M., Ferreira-Borges, C., Rumgay, H., Soerjomataram, I., & Rehm, J. (2021). Modelling the impact of increased alcohol taxation on alcohol-attributable cancers in the WHO European Region. Lancet Reg Health Eur. 11: 100225. PMID: 34918000  doi: 10.1016/j.lanepe.2021.100225
183. Li, M., Delafosse, P., Meheus, F., Borson-Chazot, F., Lifante, J. C., Simon, R., . . . Thyroid Cancer Group, F. (2021). Temporal and geographical variations of thyroid cancer incidence and mortality in France during 1986-2015: The impact of overdiagnosis. Cancer Epidemiol. 75: 102051. PMID: 34743057  doi: 10.1016/j.canep.2021.102051
184. Li, M., Zheng, R., Dal Maso, L., Zhang, S., Wei, W., & Vaccarella, S. (2021). Mapping overdiagnosis of thyroid cancer in China. Lancet Diabetes Endocrinol. 9(6): 330-332. PMID: 33891886  doi: 10.1016/S2213-8587(21)00083-8
185. Liu, B., Youlden, D. R., Wabinga, H., Nambooze, S., Amulen, P. M., Aitken, J. F., & Parkin, D. M. (2021). Survival from childhood cancer in Kampala, Uganda. Pediatr Blood Cancer. 68(3): e28876. PMID: 33381877  doi: 10.1002/pbc.28876
186. Longatto-Filho, A., Fregnani, J. H., Mafra da Costa, A., de Araujo-Souza, P. S., Scapulatempo-Neto, C., Herbster, S., . . . Termini, L. (2021). Evaluation of Elafin Immunohistochemical Expression as Marker of Cervical Cancer Severity. Acta Cytol. 65(2): 165-174. PMID: 33271565  doi: 10.1159/000512010
187. Mafra da Costa, A., Ribeiro, A. L., Ribeiro, A. G., Gini, A., Cabasag, C., Reis, R. M., . . . Soerjomataram, I. (2021). Impact of COVID-19 Pandemic on Cancer-Related Hospitalizations in Brazil. Cancer Control. 28: 10732748211038736. PMID: 34406894  doi: 10.1177/10732748211038736
188. Mandrik, O., Tolma, E., Zielonke, N., Meheus, F., Ordonez-Reyes, C., Severens, J. L., & Murillo, R. (2021). Systematic reviews as a « lens of evidence »: Determinants of participation in breast cancer screening. J Med Screen. 28(2): 70-79. PMID: 32517538  doi: 10.1177/0969141320930743
189. Marant Micallef, C., Paul, A., Charvat, H., Vignat, J., Houot, M., Pilorget, C., . . . Soerjomataram, I. (2021). An innovative method to estimate lifetime prevalence of carcinogenic occupational circumstances: the example of painters and workers of the rubber manufacturing industry in France. J Expo Sci Environ Epidemiol. 31(4): 769-776. PMID: 33144638  doi: 10.1038/s41370-020-00272-7
190. Miranda-Filho, A., Charvat, H., Bray, F., Migowski, A., Cheung, L. C., Vaccarella, S., . . . Robbins, H. A. (2021). A modeling analysis to compare eligibility strategies for lung cancer screening in Brazil. EClinicalMedicine. 42: 101176. PMID: 34765952  doi: 10.1016/j.eclinm.2021.101176
191. Miranda-Filho, A., Lortet-Tieulent, J., Bray, F., Cao, B., Franceschi, S., Vaccarella, S., & Dal Maso, L. (2021). Thyroid cancer incidence trends by histology in 25 countries: a population-based study. Lancet Diabetes Endocrinol. 9(4): 225-234. PMID: 33662333  doi: 10.1016/S2213-8587(21)00027-9
192. Morgan, E., Arnold, M., Rutherford, M. J., Bardot, A., Ferlay, J., De, P., . . . Soerjomataram, I. (2021). The impact of reclassifying cancers of unspecified histology on international differences in survival for small cell and non-small cell lung cancer (ICBP SurvMark-2 project). Int J Cancer. 149(5): 1013-1020. PMID: 33932300  doi: 10.1002/ijc.33620
193. Morgan, E., Soerjomataram, I., Gavin, A. T., Rutherford, M. J., Gatenby, P., Bardot, A., . . . Arnold, M. (2021). International trends in oesophageal cancer survival by histological subtype between 1995 and 2014. Gut. 70(2): 234-242. PMID: 32554620  doi: 10.1136/gutjnl-2020-321089
194. Musetti, C., Garau, M., Alonso, R., Pineros, M., Soerjomataram, I., & Barrios, E. (2021). Colorectal Cancer in Young and Older Adults in Uruguay: Changes in Recent Incidence and Mortality Trends. Int J Environ Res Public Health. 18(15): 8232. PMID: 34360522  doi: 10.3390/ijerph18158232
195. Parkin, D. M., Chingonzoh, T., Vuma, S., Liu, B., Chokunonga, E., Ndlovu, N., & Borok, M. (2021). Changes in the Incidence of Cancer in Bulawayo, Zimbabwe over a 50-Year Period. Cancer Epidemiol Biomarkers Prev. 30(5): 867-873. PMID: 33619023  doi: 10.1158/1055-9965.EPI-20-0669
196. Parkin, D. M., Youlden, D. R., Chitsike, I., Chokunonga, E., Couitchere, L., Gnahatin, F., . . . Aitken, J. F. (2021). Stage at diagnosis and survival by stage for the leading childhood cancers in three populations of sub-Saharan Africa. Int J Cancer. 148(11): 2685-2691. PMID: 33433927  doi: 10.1002/ijc.33468
197. Perera, S. K., Jacob, S., Wilson, B. E., Ferlay, J., Bray, F., Sullivan, R., & Barton, M. (2021). Global demand for cancer surgery and an estimate of the optimal surgical and anaesthesia workforce between 2018 and 2040: a population-based modelling study. Lancet Oncol. 22(2): 182-189. PMID: 33485458  doi: 10.1016/S1470-2045(20)30675-6
198. Pilleron, S., Charvat, H., Araghi, M., Arnold, M., Fidler-Benaoudia, M. M., Bardot, A., . . . Soerjomataram, I. (2021). Age disparities in stage-specific colon cancer survival across seven countries: An International Cancer Benchmarking Partnership SURVMARK-2 population-based study. Int J Cancer. 148(7): 1575-1585. PMID: 33006395  doi: 10.1002/ijc.33326
199. Pilleron, S., Maringe, C., Charvat, H., Atkinson, J., Morris, E., & Sarfati, D. (2021). Age disparities in lung cancer survival in New Zealand: The role of patient and clinical factors. Lung Cancer. 157: 92-99. PMID: 34006378  doi: 10.1016/j.lungcan.2021.05.015
200. Pilleron, S., Maringe, C., Charvat, H., Atkinson, J., Morris, E. J. A., & Sarfati, D. (2021). The impact of timely cancer diagnosis on age disparities in colon cancer survival. J Geriatr Oncol. 12(7): 1044-1051. PMID: 33863698  doi: 10.1016/j.jgo.2021.04.003
201. Pilleron, S., Soto-Perez-de-Celis, E., Vignat, J., Ferlay, J., Soerjomataram, I., Bray, F., & Sarfati, D. (2021). Estimated global cancer incidence in the oldest adults in 2018 and projections to 2050. Int J Cancer. 148(3): 601-608. PMID: 32706917  doi: 10.1002/ijc.33232
202. Pineros, M., Abriata, M. G., de Vries, E., Barrios, E., Bravo, L. E., Cueva, P., . . . Mery, L. (2021). Progress, challenges and ways forward supporting cancer surveillance in Latin America. Int J Cancer. 149(1): 12-20. PMID: 33231289  doi: 10.1002/ijc.33407
203. Pineros, M., Mery, L., Soerjomataram, I., Bray, F., & Steliarova-Foucher, E. (2021). Scaling Up the Surveillance of Childhood Cancer: A Global Roadmap. J Natl Cancer Inst. 113(1): 9-15. PMID: 32433739  doi: 10.1093/jnci/djaa069
204. Pineros, M., Saraiya, M., Baussano, I., Bonjour, M., Chao, A., & Bray, F. (2021). The role and utility of population-based cancer registries in cervical cancer surveillance and control. Prev Med. 144: 106237. PMID: 33678223  doi: 10.1016/j.ypmed.2020.106237
205. Puyol, M., Seoane, J., Aguilar, E., Vozza, L. B., Orbe, I., Crawford, K. H., . . . Gopal, S. (2021). WORLD CANCER RESEARCH DAY: A Call to Action for a Coordinated International Research Effort to Prevent, Diagnose, and Treat Cancer. Clin Cancer Res. 27(4): 963-966. PMID: 33257425  doi: 10.1158/1078-0432.CCR-20-2978
206. Roel, E., Pistillo, A., Recalde, M., Sena, A. G., Fernandez-Bertolin, S., Aragon, M., . . . Duarte-Salles, T. (2021). Characteristics and Outcomes of Over 300,000 Patients with COVID-19 and History of Cancer in the United States and Spain. Cancer Epidemiol Biomarkers Prev. 30(10): 1884-1894. PMID: 34272262  doi: 10.1158/1055-9965.EPI-21-0266
207. Roshandel, G., Ferlay, J., Ghanbari-Motlagh, A., Partovipour, E., Salavati, F., Aryan, K., . . . Bray, F. (2021). Cancer in Iran 2008 to 2025: Recent incidence trends and short-term predictions of the future burden. Int J Cancer. 149(3): 594-605. PMID: 33884608  doi: 10.1002/ijc.33574
208. Rovira, P., Kilian, C., Neufeld, M., Rumgay, H., Soerjomataram, I., Ferreira-Borges, C., . . . Rehm, J. (2021). Fewer Cancer Cases in 4 Countries of the WHO European Region in 2018 through Increased Alcohol Excise Taxation: A Modelling Study. Eur Addict Res. 27(3): 189-197. PMID: 33271557  doi: 10.1159/000511899
209. Rumgay, H., Arnold, M., Laversanne, M., Whiteman, D. C., Thrift, A. P., Wei, W., . . . Soerjomataram, I. (2021). International Trends in Esophageal Squamous Cell Carcinoma and Adenocarcinoma Incidence. Am J Gastroenterol. 116(5): 1072-1076. PMID: 33929382  doi: 10.14309/ajg.0000000000001121
210. Rumgay, H., Murphy, N., Ferrari, P., & Soerjomataram, I. (2021). Alcohol and Cancer: Epidemiology and Biological Mechanisms. Nutrients. 13(9). PMID: 34579050  doi: 10.3390/nu13093173
211. Rumgay, H., Shield, K., Charvat, H., Ferrari, P., Sornpaisarn, B., Obot, I., . . . Soerjomataram, I. (2021). Global burden of cancer in 2020 attributable to alcohol consumption: a population-based study. Lancet Oncol. 22(8): 1071-1080. PMID: 34270924  doi: 10.1016/S1470-2045(21)00279-5
212. Rutherford, M. J., Arnold, M., Bardot, A., Ferlay, J., De, P., Tervonen, H., . . . Soerjomataram, I. (2021). Comparison of liver cancer incidence and survival by subtypes across seven high-income countries. Int J Cancer. 149(12): 2020-2031. PMID: 34460109  doi: 10.1002/ijc.33767
213. Ryzhov, A., Corbex, M., Pineros, M., Barchuk, A., Andreasyan, D., Djanklich, S., . . . Znaor, A. (2021). Comparison of breast cancer and cervical cancer stage distributions in ten newly independent states of the former Soviet Union: a population-based study. Lancet Oncol. 22(3): 361-369. PMID: 33556324  doi: 10.1016/S1470-2045(20)30674-4
214. Seraphin, T. P., Joko-Fru, W. Y., Hammerl, L., Griesel, M., Mezger, N. C. S., Feuchtner, J. C., . . . Kantelhardt, E. J. (2021). Presentation, patterns of care, and outcomes of patients with prostate cancer in sub-Saharan Africa: A population-based registry study. Cancer. 127(22): 4221-4232. PMID: 34328216  doi: 10.1002/cncr.33818
215. Seraphin, T. P., Joko-Fru, W. Y., Kamate, B., Chokunonga, E., Wabinga, H., Somdyala, N. I. M., . . . Parkin, D. M. (2021). Rising Prostate Cancer Incidence in Sub-Saharan Africa: A Trend Analysis of Data from the African Cancer Registry Network. Cancer Epidemiol Biomarkers Prev. 30(1): 158-165. PMID: 33033143  doi: 10.1158/1055-9965.EPI-20-1005
216. Seraphin, T. P., Joko-Fru, W. Y., Manraj, S. S., Chokunonga, E., Somdyala, N. I. M., Korir, A., . . . Parkin, D. M. (2021). Prostate cancer survival in sub-Saharan Africa by age, stage at diagnosis, and human development index: a population-based registry study. Cancer Causes Control. 32(9): 1001-1019. PMID: 34244896  doi: 10.1007/s10552-021-01453-x
217. Snijders, R., Fukinsia, A., Claeys, Y., Hasker, E., Mpanya, A., Miaka, E., . . . Boelaert, M. (2021). Costs and Outcomes of Integrated Human African Trypanosomiasis Surveillance System Using Rapid Diagnostic Tests, Democratic Republic of the Congo. Emerg Infect Dis. 27(8): 2144-2153. PMID: 34287133  doi: 10.3201/eid2708.202399
218. Soerjomataram, I., & Bray, F. (2021). Planning for tomorrow: global cancer incidence and the role of prevention 2020-2070. Nat Rev Clin Oncol. 18(10): 663-672. PMID: 34079102  doi: 10.1038/s41571-021-00514-z
219. Soerjomataram, I., Ervik, M., Fox, C., Hawkins, S., Yeung, K., Napolitano, G., . . . Gavin, A. (2021). CanStaging+: an electronic staging tool for population-based cancer registries. Lancet Oncol. 22(8): 1069. PMID: 34339643  doi: 10.1016/S1470-2045(21)00188-1
220. Stoeter, O., Seraphin, T. P., Chitsike, I., Chokunonga, E., Kambugu, J. B., Wabinga, H., . . . Kantelhardt, E. J. (2021). Trends in childhood cancer incidence in sub-Saharan Africa: Results from 25 years of cancer registration in Harare (Zimbabwe) and Kyadondo (Uganda). Int J Cancer. 149(5): 1002-1012. PMID: 33945631  doi: 10.1002/ijc.33619
221. Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021). Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 71(3): 209-249. PMID: 33538338  doi: 10.3322/caac.21660
222. Vaccarella, S., & Dal Maso, L. (2021). Challenges in investigating risk factors for thyroid cancer. Lancet Diabetes Endocrinol. 9(2): 57-59. PMID: 33347808  doi: 10.1016/S2213-8587(20)30426-5
223. Vaccarella, S., Ginsburg, O., & Bray, F. (2021). Gender inequalities in cancer among young adults. Lancet Oncol. 22(2): 166-167. PMID: 33539738  doi: 10.1016/S1470-2045(21)00001-2
224. Vaccarella, S., Lortet-Tieulent, J., Colombet, M., Davies, L., Stiller, C. A., Schuz, J., . . . contributors, I.-. (2021). Global patterns and trends in incidence and mortality of thyroid cancer in children and adolescents: a population-based study. Lancet Diabetes Endocrinol. 9(3): 144-152. PMID: 33482107  doi: 10.1016/S2213-8587(20)30401-0
225. Yang, Z., Yang, J., Li, M. M., Chen, J. J., & Ou, C. Q. (2021). Nonlinear and lagged meteorological effects on daily levels of ambient PM2.5 and O-3: Evidence from 284 Chinese cities. J Clean Prod. 278: 10. doi: 10.1016/j.jclepro.2020.123931
226. Znaor, A., Fouad, H., Majnoni d’Intignano, F., Hammerich, A., Slama, S., Pourghazian, N., . . . Bray, F. (2021). Use of cancer data for cancer control in the Eastern Mediterranean Region: Results of a survey among population-based cancer registries. Int J Cancer. 148(3): 593-600. PMID: 32683692  doi: 10.1002/ijc.33223
227. Znaor, A., Ryzhov, A., Corbex, M., Pineros, M., & Bray, F. (2021). Cervical cancer in the Newly Independent States of the former Soviet Union: Incidence will remain high without action. Cancer Epidemiol. 73: 101944. PMID: 33975255  doi: 10.1016/j.canep.2021.101944
228. Araghi, M., Roshandel, G., Hasanpour-Heidari, S., Fazel, A., Sedaghat, S. M., Pourkhani, A., . . . Arnold, M. (2020). Incidence of Malignant Brain and Central Nervous System Tumors in Golestan, Iran, 2004-2013. Arch Iran Med. 23(1): 1-6. PMID: 31910628
229. Arbyn, M., Weiderpass, E., Bruni, L., de Sanjose, S., Saraiya, M., Ferlay, J., & Bray, F. (2020). Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Glob Health. 8(2): e191-e203. PMID: 31812369 doi: 10.1016/s2214-109x(19)30482-6
230. Armaroli, P., Riggi, E., Basu, P., Anttila, A., Ponti, A., Carvalho, A. L., . . . Segnan, N. (2020). Performance indicators in breast cancer screening in the European Union: A comparison across countries of screen positivity and detection rates. Int J Cancer. 147(7): 1855-1863. PMID: 32159224 doi: 10.1002/ijc.32968
231. Arnold, M., Abnet, C. C., Neale, R. E., Vignat, J., Giovannucci, E. L., McGlynn, K. A., & Bray, F. (2020). Global Burden of 5 Major Types of Gastrointestinal Cancer. Gastroenterology. 159(1): 335-349 e315. PMID: 32247694 doi: 10.1053/j.gastro.2020.02.068
232. Arnold, M., Ferlay, J., van Berge Henegouwen, M. I., & Soerjomataram, I. (2020). Global burden of oesophageal and gastric cancer by histology and subsite in 2018. Gut. 69(9): 1564-1571. PMID: 32606208 doi: 10.1136/gutjnl-2020-321600
233. Arnold, M., Park, J. Y., Camargo, M. C., Lunet, N., Forman, D., & Soerjomataram, I. (2020). Is gastric cancer becoming a rare disease? A global assessment of predicted incidence trends to 2035. Gut. 69(5): 823-829. PMID: 32001553 doi: 10.1136/gutjnl-2019-320234
234. Atun, R., Bhakta, N., Denburg, A., Frazier, A. L., Friedrich, P., Gupta, S., . . . Rodriguez-Galindo, C. (2020). Sustainable care for children with cancer: a Lancet Oncology Commission. Lancet Oncol. 21(4): e185-e224. PMID: 32240612 doi: 10.1016/s1470-2045(20)30022-x
235. Bansal, S., Deshpande, V., Zhao, X., Lauer, J. A., Meheus, F., Ilbawi, A., & Gopalappa, C. (2020). Analysis of Mammography Screening Schedules under Varying Resource Constraints for Planning Breast Cancer Control Programs in Low- and Middle-Income Countries: A Mathematical Study. Med Decis Making. 40(3): 364-378. PMID: 32160823 doi: 10.1177/0272989X20910724
236. Barr, R. D., Ries, L. A. G., Trama, A., Gatta, G., Steliarova-Foucher, E., Stiller, C. A., & Bleyer, W. A. (2020). A system for classifying cancers diagnosed in adolescents and young adults. Cancer. 126(21): 4634-4659. PMID: 32901932 doi: 10.1002/cncr.33041
237. Bray, F., Laversanne, M., Weiderpass, E., & Arbyn, M. (2020). Geographic and temporal variations in the incidence of vulvar and vaginal cancers. Int J Cancer. 147(10): 2764-2771. PMID: 32410226 doi: 10.1002/ijc.33055
238. Brisson, M., Kim, J. J., Canfell, K., Drolet, M., Gingras, G., Burger, E. A., . . . Hutubessy, R. (2020). Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries. Lancet. 395(10224): 575-590. PMID: 32007141 doi: 10.1016/s0140-6736(20)30068-4
239. Cabasag, C. J., Arnold, M., Butler, J., Inoue, M., Trabert, B., Webb, P. M., . . . Soerjomataram, I. (2020). The influence of birth cohort and calendar period on global trends in ovarian cancer incidence. Int J Cancer. 146(3): 749-758. PMID: 30968402 doi: 10.1002/ijc.32322
240. Cabasag, C. J., Butler, J., Arnold, M., Rutherford, M., Bardot, A., Ferlay, J., . . . Soerjomataram, I. (2020). Exploring variations in ovarian cancer survival by age and stage (ICBP SurvMark-2): A population-based study. Gynecol Oncol. 157(1): 234-244. PMID: 32005583 doi: 10.1016/j.ygyno.2019.12.047
241. Canfell, K., Kim, J. J., Brisson, M., Keane, A., Simms, K. T., Caruana, M., . . . Hutubessy, R. (2020). Mortality impact of achieving WHO cervical cancer elimination targets: a comparative modelling analysis in 78 low-income and lower-middle-income countries. Lancet. 395(10224): 591-603. PMID: 32007142 doi: 10.1016/s0140-6736(20)30157-4
242. Culp, M. B., Soerjomataram, I., Efstathiou, J. A., Bray, F., & Jemal, A. (2020). Recent Global Patterns in Prostate Cancer Incidence and Mortality Rates. Eur Urol. 77(1): 38-52. PMID: 31493960 doi: 10.1016/j.eururo.2019.08.005
243. de Martel, C., Georges, D., Bray, F., Ferlay, J., & Clifford, G. M. (2020). Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis. Lancet Glob Health. 8(2): e180-e190. PMID: 31862245 doi: 10.1016/s2214-109x(19)30488-7
244. Di Credico, G., Polesel, J., Dal Maso, L., Pauli, F., Torelli, N., Luce, D., . . . Edefonti, V. (2020). Alcohol drinking and head and neck cancer risk: the joint effect of intensity and duration. Br J Cancer. 123(9): 1456-1463. PMID: 32830199 doi: 10.1038/s41416-020-01031-z
245. Diaz, A., Soerjomataram, I., Moore, S., Whop, L. J., Bray, F., Hoberg, H., & Garvey, G. (2020). Collection and Reporting of Indigenous Status Information in Cancer Registries Around the World. JCO Glob Oncol. 6: 133-142. PMID: 32031453 doi: 10.1200/JGO.19.00119
246. Fidler-Benaoudia, M. M., Torre, L. A., Bray, F., Ferlay, J., & Jemal, A. (2020). Lung cancer incidence in young women vs. young men: A systematic analysis in 40 countries. Int J Cancer. 147(3): 811-819. PMID: 32020598 doi: 10.1002/ijc.32809
247. Florio, A. A., Ferlay, J., Znaor, A., Ruggieri, D., Alvarez, C. S., Laversanne, M., . . . Petrick, J. L. (2020). Global trends in intrahepatic and extrahepatic cholangiocarcinoma incidence from 1993 to 2012. Cancer. 126(11): 2666-2678. PMID: 32129902 doi: 10.1002/cncr.32803
248. Gadgil, A., Sauvaget, C., Roy, N., Muwonge, R., Lucas, E., & Sankaranarayanan, R. (2020). Setting up a Breast Cancer Awareness Project in Mumbai: Methodology, Experiences and Challenges. J Cancer Educ. 35(3): 579-588. PMID: 30863980 doi: 10.1007/s13187-019-01500-x
249. Gupta, S., Aitken, J., Bartels, U., Bhakta, N., Bucurenci, M., Brierley, J. D., . . . Frazier, A. L. (2020). Development of paediatric non-stage prognosticator guidelines for population-based cancer registries and updates to the 2014 Toronto Paediatric Cancer Stage Guidelines. Lancet Oncol. 21(9): e444-e451. PMID: 32888473 doi: 10.1016/S1470-2045(20)30320-X
250. Gupta, S., Harper, A., Ruan, Y., Barr, R., Frazier, A. L., Ferlay, J., . . . Fidler-Benaoudia, M. M. (2020). International Trends in the Incidence of Cancer Among Adolescents and Young Adults. J Natl Cancer Inst. 112(11): 1105-1117. PMID: 32016323 doi: 10.1093/jnci/djaa007
251. Hall, A. L., Kromhout, H., Schuz, J., Peters, S., Portengen, L., Vermeulen, R., . . . Olsson, A. (2020). Laryngeal Cancer Risks in Workers Exposed to Lung Carcinogens: Exposure-Effect Analyses Using a Quantitative Job Exposure Matrix. Epidemiology. 31(1): 145-154. PMID: 31577634 doi: 10.1097/ede.0000000000001120
252. Hanly, P., Ortega Ortega, M., Pearce, A., Soerjomataram, I., & Sharp, L. (2020). Advances in the methodological approach to friction period estimation: A European perspective. Soc Sci Med. 264: 113289. PMID: 32836019 doi: 10.1016/j.socscimed.2020.113289
253. Hassler, M. R., Bray, F., Catto, J. W. F., Grollman, A. P., Hartmann, A., Margulis, V., . . . Faltas, B. M. (2020). Molecular Characterization of Upper Tract Urothelial Carcinoma in the Era of Next-generation Sequencing: A Systematic Review of the Current Literature. Eur Urol. 78(2): 209-220. PMID: 32571725 doi: 10.1016/j.eururo.2020.05.039
254. Ilbawi, A., Dhaene, G., Meheus, F., & Bertram, M. (2020). Opportunities to improve cancer control and progress towards universal health coverage in Commonwealth nations. Lancet Oncol. 21(7): 876-879. PMID: 32615104 doi: 10.1016/S1470-2045(20)30245-X
255. Jafari-Delouei, N., Naeimi-Tabiei, M., Fazel, A., Ashaari, M., Hatami, E., Sedaghat, S. M., . . . Roshandel, G. (2020). Descriptive Epidemiology of Lymphoma in Northern Iran: Results from the Golestan Registry 2004-2013. Arch Iran Med. 23(3): 150-154. PMID: 32126782
256. Ji, X. W., Jiang, Y., Wu, H., Zhou, P., Tan, Y. T., Li, H. L., . . . Xiang, Y. B. (2020). Long-term liver cancer incidence and mortality trends in the Changning District of Shanghai, China. J Dig Dis. 21(4): 230-236. PMID: 32124559 doi: 10.1111/1751-2980.12855
257. Joko-Fru, W. Y., Jedy-Agba, E., Korir, A., Ogunbiyi, O., Dzamalala, C. P., Chokunonga, E., . . . Parkin, D. M. (2020). The evolving epidemic of breast cancer in sub-Saharan Africa: Results from the African Cancer Registry Network. Int J Cancer. 147(8): 2131-2141. PMID: 32306390 doi: 10.1002/ijc.33014
258. Joko-Fru, W. Y., Miranda-Filho, A., Soerjomataram, I., Egue, M., Akele-Akpo, M. T., N’da, G., . . . Parkin, D. M. (2020). Breast cancer survival in sub-Saharan Africa by age, stage at diagnosis and human development index: A population-based registry study. Int J Cancer. 146(5): 1208-1218. PMID: 31087650 doi: 10.1002/ijc.32406
259. Kreimer, A. R., Chaturvedi, A. K., Alemany, L., Anantharaman, D., Bray, F., Carrington, M., . . . Brennan, P. (2020). Summary from an international cancer seminar focused on human papillomavirus (HPV)-positive oropharynx cancer, convened by scientists at IARC and NCI. Oral Oncol. 108: 104736. PMID: 32502860 doi: 10.1016/j.oraloncology.2020.104736
260. Kulhanova, I., Forman, D., Vignat, J., Espina, C., Brenner, H., Storm, H. H., . . . Soerjomataram, I. (2020). Tobacco-related cancers in Europe: The scale of the epidemic in 2018. Eur J Cancer. 139: 27-36. PMID: 32957011 doi: 10.1016/j.ejca.2020.07.024
261. Kulhanova, I., Znaor, A., Shield, K. D., Arnold, M., Vignat, J., Charafeddine, M., . . . Soerjomataram, I. (2020). Proportion of cancers attributable to major lifestyle and environmental risk factors in the Eastern Mediterranean region. Int J Cancer. 146(3): 646-656. PMID: 30882889 doi: 10.1002/ijc.32284
262. Lambert, P. C., Andersson, T. M., Rutherford, M. J., Myklebust, T. A., & Moller, B. (2020). Reference-adjusted and standardized all-cause and crude probabilities as an alternative to net survival in population-based cancer studies. Int J Epidemiol. 49(5): 1614-1623. PMID: 32829393 doi: 10.1093/ije/dyaa112
263. Li, M., Brito, J. P., & Vaccarella, S. (2020). Long-Term Declines of Thyroid Cancer Mortality: An International Age-Period-Cohort Analysis. Thyroid. 30(6): 838-846. PMID: 31964280 doi: 10.1089/thy.2019.0684
264. Li, M., Dal Maso, L., & Vaccarella, S. (2020). Global trends in thyroid cancer incidence and the impact of overdiagnosis. Lancet Diabetes Endocrinol. 8(6): 468-470. PMID: 32445733 doi: 10.1016/S2213-8587(20)30115-7
265. Lorenzoni, C. F., Ferro, J., Carrilho, C., Colombet, M., & Parkin, D. M. (2020). Cancer in Mozambique: Results from two population-based cancer registries. Int J Cancer. 147(6): 1629-1637. PMID: 32142162 doi: 10.1002/ijc.32953
266. Lortet-Tieulent, J., Georges, D., Bray, F., & Vaccarella, S. (2020). Profiling global cancer incidence and mortality by socioeconomic development. Int J Cancer. 147(11): 3029-3036. PMID: 32449164 doi: 10.1002/ijc.33114
267. Mhatre, S., Rajaraman, P., Chatterjee, N., Bray, F., Goel, M., Patkar, S., . . . Dikshit, R. (2020). Mustard oil consumption, cooking method, diet and gallbladder cancer risk in high- and low-risk regions of India. Int J Cancer. 147(6): 1621-1628. PMID: 32142159 doi: 10.1002/ijc.32952
268. Miranda-Filho, A., & Bray, F. (2020). Global patterns and trends in cancers of the lip, tongue and mouth. Oral Oncol. 102: 104551. PMID: 31986342 doi: 10.1016/j.oraloncology.2019.104551
269. Miranda-Filho, A., Bray, F., Charvat, H., Rajaraman, S., & Soerjomataram, I. (2020). The world cancer patient population (WCPP): An updated standard for international comparisons of population-based survival. Cancer Epidemiol. 69: 101802. PMID: 32942139 doi: 10.1016/j.canep.2020.101802
270. Miranda-Filho, A., Pineros, M., Ferreccio, C., Adsay, V., Soerjomataram, I., Bray, F., & Koshiol, J. (2020). Gallbladder and extrahepatic bile duct cancers in the Americas: Incidence and mortality patterns and trends. Int J Cancer. 147(4): 978-989. PMID: 31922259 doi: 10.1002/ijc.32863
271. Myklebust, T. A., Andersson, T., Bardot, A., Vernon, S., Gavin, A., Fitzpatrick, D., . . . Moller, B. (2020). Can different definitions of date of cancer incidence explain observed international variation in cancer survival? An ICBP SURVMARK-2 study. Cancer Epidemiol. 67: 101759. PMID: 32544801 doi: 10.1016/j.canep.2020.101759
272. Nakata, K., Colombet, M., Stiller, C. A., Pritchard-Jones, K., & Steliarova-Foucher, E. (2020). Incidence of childhood renal tumours: An international population-based study. Int J Cancer. 147(12): 3313-3327. PMID: 32902866 doi: 10.1002/ijc.33147
273. Noh, H., Charvat, H., Freisling, H., Olafsdottir, G. H., Olafsdottir, E. J., Tryggvadottir, L., . . . Soerjomataram, I. (2020). Cumulative exposure to premenopausal obesity and risk of postmenopausal cancer: A population-based study in Icelandic women. Int J Cancer. 147(3): 793-802. PMID: 31755107 doi: 10.1002/ijc.32805
274. Norell, C. H., Butler, J., Farrell, R., Altman, A., Bentley, J., Cabasag, C. J., . . . Harrison, S. (2020). Exploring international differences in ovarian cancer treatment: a comparison of clinical practice guidelines and patterns of care. Int J Gynecol Cancer. 30(11): 1748-1756. PMID: 32784203 doi: 10.1136/ijgc-2020-001403
275. Panato, C., Vaccarella, S., Dal Maso, L., Basu, P., Franceschi, S., Serraino, D., . . . Mathew, A. (2020). Thyroid Cancer Incidence in India Between 2006 and 2014 and Impact of Overdiagnosis. J Clin Endocrinol Metab. 105(8): 2507-2514. PMID: 32297630 doi: 10.1210/clinem/dgaa192
276. Parkin, D. M., Hammerl, L., Ferlay, J., & Kantelhardt, E. J. (2020). Cancer in Africa 2018: The role of infections. Int J Cancer. 146(8): 2089-2103. PMID: 31254479 doi: 10.1002/ijc.32538
277. Petrick, J. L., Florio, A. A., Znaor, A., Ruggieri, D., Laversanne, M., Alvarez, C. S., . . . McGlynn, K. A. (2020). International trends in hepatocellular carcinoma incidence, 1978-2012. Int J Cancer. 147(2): 317-330. PMID: 31597196 doi: 10.1002/ijc.32723
278. Pilleron, S., Cabasag, C. J., Ferlay, J., Bray, F., Luciani, S., Almonte, M., & Pineros, M. (2020). Cervical cancer burden in Latin America and the Caribbean: Where are we? Int J Cancer. 147(6): 1638-1648. PMID: 32150288 doi: 10.1002/ijc.32956
279. Ponti, A., Basu, P., Ritchie, D., Anttila, A., Carvalho, A. L., Senore, C., . . . Segnan, N. (2020). Key issues that need to be considered while revising the current annex of the European Council Recommendation (2003) on cancer screening. Int J Cancer. 147(1): 9-13. PMID: 31970768 doi: 10.1002/ijc.32885
280. Roshandel, G., Ferlay, J., Semnani, S., Fazel, A., Naeimi-Tabiei, M., Ashaari, M., . . . Bray, F. (2020). Recent cancer incidence trends and short-term predictions in Golestan, Iran 2004-2025. Cancer Epidemiol. 67: 101728. PMID: 32554298 doi: 10.1016/j.canep.2020.101728
281. Ryzhov, A., Bray, F., Ferlay, J., Fedorenko, Z., Goulak, L., Gorokh, Y., . . . Znaor, A. (2020). Recent cancer incidence trends in Ukraine and short-term predictions to 2022. Cancer Epidemiol. 65: 101663. PMID: 31882366 doi: 10.1016/j.canep.2019.101663
282. Salamat, F., Khandashpour, M., Naeimi-Tabiei, M., Ariannia, A., Ashaari, M., Sedaghat, S., . . . Weiderpass, E. (2020). Increasing trends of lung cancer in Golestan province, Northern Iran (2004-2016). Cancer Epidemiol. 65: 101687. PMID: 32087554 doi: 10.1016/j.canep.2020.101687
283. Sangrajrang, S., Laversanne, M., Bausom, R., Mery, L., & Bray, F. (2020). Cancer incidence and cancer control in Bangkok, Thailand: Results from the cancer registry 2011-15 and projections to 2035. Cancer Epidemiol. 67: 101765. PMID: 32585431 doi: 10.1016/j.canep.2020.101765
284. Sengayi-Muchengeti, M., Joko-Fru, W. Y., Miranda-Filho, A., Egue, M., Akele-Akpo, M. T., N’da, G., . . . Parkin, D. M. (2020). Cervical cancer survival in sub-Saharan Africa by age, stage at diagnosis and Human Development Index: A population-based registry study. Int J Cancer. 147(11): 3037-3048. PMID: 32449157 doi: 10.1002/ijc.33120
285. Snijders, R., Fukinsia, A., Claeys, Y., Mpanya, A., Hasker, E., Meheus, F., . . . Boelaert, M. (2020). Cost of a new method of active screening for human African trypanosomiasis in the Democratic Republic of the Congo. PLoS Negl Trop Dis. 14(12): e0008832. PMID: 33315896 doi: 10.1371/journal.pntd.0008832
286. Vaccarella, S., & Bray, F. (2020). Are U.S. trends a barometer of future cancer transitions in emerging economies? Int J Cancer. 146(6): 1499-1502. PMID: 31162837 doi: 10.1002/ijc.32485
287. Wei, W., Zeng, H., Zheng, R., Zhang, S., An, L., Chen, R., . . . He, J. (2020). Cancer registration in China and its role in cancer prevention and control. Lancet Oncol. 21(7): e342-e349. PMID: 32615118 doi: 10.1016/S1470-2045(20)30073-5
288. Yang, J., Zhou, M., Li, M., Yin, P., Hu, J., Zhang, C., . . . Wang, B. (2020). Fine particulate matter constituents and cause-specific mortality in China: A nationwide modelling study. Environ Int. 143: 105927. PMID: 32619910 doi: 10.1016/j.envint.2020.105927
289. Znaor, A., Skakkebaek, N. E., Rajpert-De Meyts, E., Laversanne, M., Kulis, T., Gurney, J., . . . Bray, F. (2020). Testicular cancer incidence predictions in Europe 2010-2035: A rising burden despite population ageing. Int J Cancer. 147(3): 820-828. PMID: 31773729 doi: 10.1002/ijc.32810